Race Oncology
Sophia Moscovis PhD, GAICD is a seasoned professional in healthcare innovation and operational strategy, currently serving as Vice President of Operations & Strategy at Race Oncology and as a Healthcare Innovation Contributor for Forbes Australia and an Independent Consultant for Digital Health & Healthcare Transformation. With extensive experience at Novartis, where Sophia held multiple roles including Business Transformation Lead and Field Medical Excellence Lead, expertise spans across program management and risk strategy. Sophia also acts as a Strategic Advisor for Auric Experiences and is a Keynote Speaker for Saxton Group. Academic credentials include a PhD in Immunology & Microbiology from the University of Newcastle, and recent training in Project Management from MIT xPRO.
This person is not in any teams
Race Oncology
Race Oncology (ASX: RAC) is a precision oncology company with a Phase II/III cancer drug called Bisantrene.